The Behavioral Risk Factor Surveillance System (BRFSS) is a system of health-related telephone surveys that collect state data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. BRFSS collects data in all 50 states as well as the District of Columbia and three U.S. territories. BRFSS collects state data about U.S. residents regarding their health-related risk behaviors and events, chronic health conditions, and use of preventive services. BRFSS also collects data on important emerging health issues such as vaccine shortage and influenza-like illness. Interviewers administer the annual BRFSS surveys continuously through the year.

The National Survey on Drug Use and Health (NSDUH) provides national and state-level data on the use of tobacco, alcohol, illicit drugs (including non-medical use of prescription drugs) and mental health in the United States. This annual survey involves interviews with approximately 70,000 randomly selected individuals aged 12 and older. NSDUH is sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency of the U.S. Public Health Service in the U.S. Department of Health and Human Services (DHHS).

The surveys' primary purpose is to monitor priority health risk behaviors that contribute to the leading causes of mortality, morbidity, and social problems among youth in New York City. Students complete a self-administered, anonymous questionnaire that measures a variety of behaviors, including tobacco, alcohol and drug use, unintentional injury and violence, sexual behaviors, dietary behaviors, and physical activity. The results are representative of public high school students in grades 9 through 12.

This study contains two surveys concerning self-reported use of novel psychoactive substances (NPSs) and other drugs among Electronic Dance Music (EDM) and dance enthusiasts. The first survey was conducted in the summer of 2015. 682 nightclub and festival attendees between 18 and 25 years of age were surveyed as they entered parties. The second survey was conducted in the summer of 2016 on a new group of participants. 1048 people were surveyed between 18 and 40 years of age. During both rounds of data collection, those surveyed were asked about their age, sex, race, ethnicity, level of educational attainment, sexual orientation, parental educational attainment, weekly income, religiosity, frequency of attending nightclubs or festivals, lifetime use of more than 100 isolated NPSs, and lifetime use of traditional drugs.

The New York City Community Health Survey (CHS) is a telephone survey conducted annually by the DOHMH, Division of Epidemiology, Bureau of Epidemiology Services. CHS provides robust data on the health of New Yorkers, including neighborhood, borough, and citywide estimates on a broad range of chronic diseases and behavioral risk factors.

The Monitoring the Future: A Continuing Study of the Lifestyles and Values of Youth annual surveys explore changes in important values, behaviors, and lifestyle orientations of contemporary American youth. Each year, large, distinct, nationally representative samples of 8th-, 10th-, and 12th-grade students in the United States are asked to respond to drug use and demographic questions, as well as to additional questions on a variety of subjects, including attitudes toward religion, parental influences, changing roles of women, educational aspirations, self-esteem, exposure to sex and drug education, and violence and crime - both in and out of school. In each grade, students are randomly assigned to complete questionnaires with a subset of topical questions in addition to a set of core questions on demographics and drug use.

The Framingham Heart Study (FHS) is dedicated to identifying common factors or characteristics that contribute to cardiovascular disease (CVD). In 1948, an original cohort of 5,209 men and women between 30 and 62 years old were recruited from Framingham, MA. An Offspring Cohort began in 1971, an Omni Cohort in 1994, a Third Generation Cohort in 2002, a New Offspring Spouse Cohort in 2004 and a Second Generation Omni Cohort in 2003. Core research in the dataset focuses on cardiovascular and cerebrovascular diseases. The data include biological specimens, molecular genetic data, phenotype data, samples, images, participant vascular functioning data, physiological data, demographic data, and ECG data.It is a collaborative project of the National Heart, Lung and Blood Institute and Boston University.

This on-going prospective cohort study examines a wide range of individual-, social- and structural-level factors as predictors of risk and resilience for behavioral outcomes (licit and illicit substance use and sexual activity, etc.), mental health conditions (depressions, anxiety, etc.) and biological outcomes (HIV seroconversion, viral and bacterial STIs) in a NYC metro area based sample of emerging adult men. The study applies a theory of syndemic production to examine these overlapping health states in a cohort of racially/ethnically and socioeconomically diverse young men.

The Racial and Ethnic Approaches to Community Health across the U.S. (REACH U.S.) is a CDC effort to eliminate ethnic and racial health disparities. The REACH U.S. Risk Factor Survey was conducted between 2009 and 2013 in order to monitor progress and achievements in the REACH U.S. program. The survey was conducted annually between 2009 and 2013 in 28 REACH U.S. grantee communities to gather health-related information in areas where REACH U.S. community health interventions were taking place. Adults aged 18 years or older in the REACH community were surveyed by phone, mail, or in-person. Communities surveyed included areas of Arizona, California, Georgia, Hawaii, Illinois, Massachusetts, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Virginia, Washington, and West Virginia. Approximately 1,000 surveys were conducted in each of the 28 communities in each of the four years. Surveillance Summaries are available.

Schizophrenic patients have a high rate of smoking and cognitive deficits which may be related to a decreased number or responsiveness of nicotinic receptors in their brains. Varenicline is a partial nicotinc agonist which is effects as an anti-smoking drug in cigarette smokers, although concerns have been raised about potential psychiatric side-effects. This data is from a double-blind placebo controlled study in 87 schizophrenic smokers to evaluate the effect of varenicline on measures of smoking, cognition, psychiatric symptoms, and side-effects in schizophrenic patients who are cigarette smokers.